Dathan M. Byonanebye

Author

Also Known As

Byonanebye M. Dathan, D. M. Byonanebye, Dathan Byonanebye, Dathan M Byonanebye, Dathan M. Byonanebye, Dathan Mirembe Byonanebye, Jain, Vivek, Petersen, Maya L., Pontiano Kaleebu, The RESPOND Study Group∗

Publications

Citations

H-Index

Concepts

All Affiliations

Makerere University University of California, San Francisco Infectious Diseases Research Collaboration University of California, Berkeley San Francisco General Hospital

About

Dathan M. Byonanebye is an author at Makerere University specializing in epidemiology, hiv, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	63
2	Public Health	2	2	63
3	Epidemiology	2	2	63
4	Global Health	1	1	41
5	Risk	1	1	41

Dathan M. Byonanebye

Publications

894

Citations

H-Index

Page 1

	Year	Citations
HIV Testing and Treatment with the Use of a Community Health Approach in Rural Africa Diane V. Havlir, Laura B. Balzer, Edwin D. Charlebois, New England Journal of Medicine	2019	216
Hypertension control in integrated HIV and chronic disease clinics in Uganda in the SEARCH study Dalsone Kwarisiima, Mucunguzi Atukunda, Asiphas Owaraganise, BMC Public Health	2019	114
Population-Based Assessment of Hypertension Epidemiology and Risk Factors among HIV-Positive and General Populations in Rural Uganda Dalsone Kwarisiima, Laura B. Balzer, David J. Heller, PLoS ONE	2016	95
High rates of viral suppression in adults and children with high CD4+ counts using a streamlined ART delivery model in the SEARCH trial in rural Uganda and Kenya Dalsone Kwarisiima, Moses R. Kamya, Asiphas Owaraganise, Journal of the International AIDS Society	2017	76
Evaluating linkage to care for hypertension after community‐based screening in rural <scp>U</scp>ganda Prashant Kotwani, Laura B. Balzer, Dalsone Kwarisiima, Tropical Medicine & International Health	2014	67
Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium Dathan M. Byonanebye, Mark N. Polizzotto, Bastian Neesgaard, HIV Medicine	2022	60
Impact of a mobile phone-based interactive voice response software on tuberculosis treatment outcomes in Uganda (CFL-TB): a protocol for a randomized controlled trial Dathan M. Byonanebye, Hope Mackline, Christine Sekaggya‐Wiltshire, Trials	2021	46
Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts Dathan M. Byonanebye, Mark N. Polizzotto, Fernando Maltêz, The Lancet HIV Respond Consortium CohortsHypertensionPreventive MedicineCardiovascular EpidemiologyCardiovascular Disease	2024	41
An Interactive Voice Response Software to Improve the Quality of Life of People Living With HIV in Uganda: Randomized Controlled Trial Dathan M. Byonanebye, Maria Sarah Nabaggala, Agnes Bwanika Naggirinya, JMIR mhealth and uhealth	2021	37
Successful antiretroviral therapy delivery and retention in care among asymptomatic individuals with high CD4+ T-cell counts above 350 cells/μl in rural Uganda Vivek Jain, Dathan M. Byonanebye, Gideon Amanyire, AIDS	2014	30

Page 1